pyridostigmine bromide

(redirected from Mestinon)
Also found in: Medical.

pyridostigmine bromide

[¦pir·ə·dō′stig‚mēn ′brō‚mīd]
(pharmacology)
C9H13O2NBr A white, crystalline powder with a melting point of 154-157°C; soluble in water, alcohol, and chloroform; used in medicine.
References in periodicals archive ?
Fred Wilkinson, President and Chief Executive Office of Impax stated, "We are pleased to receive approval of generic Mestinon Timespan Tablets, as this is the first generic product approved from the Hayward, CA facility following the resolution of the warning letter on September 4, 2015.
She did say that her liver enzymes tended to be slightly elevated with the Mestinon.
The new agreement - which is announced today - will mean that Valeant sales specialists will promote the benefits of Symmetrel to neurologists alongside Valeant's own product Mestinon, while the Alliance sales team will promote the benefits of Mestinon in addition to Symmetrel.
In the cours eof those 8 days, she was introduced to another, and more durable, anticholinesterase agent, called, Mestinon, and an effective dosage (one 60-milligram tablet every four hours) was determined.
Efudex, Cesamet, Diastat AcuDial, Kinerase, Mestinon, Zelapar, Migranal, Bedoyecta, Dermatix and Bisocard are trademarks or registered trademarks of Valeant Pharmaceuticals International or its related companies.
Efudex, Diastat AcuDial, Kinerase, Mestinon, Zelapar, Migranal, Bedoyecta, Dermatix and Bisocard are trademarks or registered trademarks of Valeant Pharmaceuticals International or its related companies.
Results in Europe were driven by an increase in sales of Mestinon and Calcitonin(R), along with a growing contribution from Dermatix(R), which was introduced by the company earlier in the year.
Sales of Mestinon, Bisocard and Dermatix increased in the third quarter, which were offset by a decrease in vision care products due to the divestment of the company's ophthalmic business in the Netherlands earlier in 2007.
Sales of several promoted products were higher, including Solcoseryl, Bisocard and Mestinon.
Efudex, Cesamet, Kinerase, Mestinon, Bedoyecta, Solcoseryl and Bisocard are trademarks or registered trademarks of Valeant Pharmaceuticals International or its related companies.
Several promoted products performed well in Europe, including Mestinon, Efudex, Solcoseryl[TM] and Bisocard[TM].
The largest product sales in EMEA included Mestinon, Solcoseryl[TM] and Bisocard[TM].